Prime Therapeutics Executives to Discuss Payer Strategies for Hepatitis C Treatment, Costs

Share Article

In the Dec. 8 webinar from Atlantic Information Services, participants will learn about strategies insurers can employ to improve outcomes for people with hepatitis C while managing costs in a responsible way.

Since 2011, the FDA has approved five new drugs to treat hepatitis C, with more expected to launch soon. With the approvals have come improved cure rates and decreased side effects compared with older regimens, but innovation hasn’t come cheap. The Dec. 8 webinar from Atlantic Information Services, Inc. (AIS), “Hepatitis C Treatment: Payer Strategies to Improve Outcomes and Contain Costs,” will discuss what strategies payers should use to evaluate today’s costly treatment options (and those in the pipeline) and make sure patients receive care that is appropriate for each individual.

During 60 minutes of presentations followed by 30 minutes devoted to individual questions, two industry experts from Prime Therapeutics — Patrick Gleason, Pharm.D., FCCP, BCPS, and Kirsten Tiberg, R.Ph. — will provide valuable perspectives about:

  • The efficacy and cost of today’s therapies, and the impact new drugs in the pipeline are likely to have on current treatment choices
  • Diagnoses of hepatitis C stages and the impact on treatment
  • A three-year hepatitis C drug class impact model that uses integrated medical and pharmacy claims to forecast utilization and costs
  • The influence of member cost share on adherence, and the impact that pharmaceutical manufacturer copay offsets have in managing hepatitis C and other costly specialty drug treatments
  • Methods to identify and remove barriers to complicated treatment regimens to help boost adherence
  • Ways to align efforts to manage specialty hepatitis C drug treatments, including utilization management, care management, channel management, rebate/formulary management and benefit design

Visit http://aishealth.com/marketplace/c4p42_120814 for more details and registration information.

About AIS
Atlantic Information Services, Inc. (AIS) is a publishing and information company that has been serving the health care industry for more than 25 years. It develops highly targeted news, data and strategic information for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. AIS products include print and electronic newsletters, websites, looseleafs, books, strategic reports, databases, webinars and conferences. Learn more at http://www.AISHealth.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Shelly Beaird-Francois
Atlantic Information Services
+1 (202) 775-9008 Ext: 3064
Email >
@AISPharmacy
since: 01/2011
Follow >
AISHealth
since: 01/2011
Like >
Atlantic Information Services, Inc.

Visit website